BioTech and ClimateTech are two emerging DeepTech investment trends that will show strength for the rest of the decade, says Dr Riam Kanso, Founder and CEO of Conception X. “We’re going to look back at this era as the moment where biology became software,” she explains, comparing it to the impact cloud computing had on business. Kanso adds that ClimateTech startup investment exceeded $17 billion globally last year and that interest will only increase.
In this video interview, Kanso also explains the fundamentals of DeepTech, how Conception X helps inexperienced PhD students get their ideas to market and wraps up with some practical advice for DeepTech startups looking to win investment.
Barclays (including its employees, Directors and agents) accepts no responsibility and shall have no liability in contract, tort or otherwise to any person in connection with this content or the use of or reliance on any information or data set out in this content unless it expressly agrees otherwise in writing. It does not constitute an offer to sell or buy any security, investment, financial product or service and does not constitute investment, professional, legal or tax advice, or a recommendation with respect to any securities or financial instruments.
The information, statements and opinions contained in this content are of a general nature only and do not take into account your individual circumstances including any laws, policies, procedures or practices you, or your employer or businesses may have or be subject to. Although the statements of fact on this page have been obtained from and are based upon sources that Barclays believes to be reliable, Barclays does not guarantee their accuracy or completeness.